Clinical Trial: Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia
Study Status: Completed
Recruit Status: Completed
Condition: Rabies Post-exposure Prophylaxis
Study Type: Observational
Official Title: Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia
Brief Summary:
A rabies virus neutralizing antibody (RVNA) concentration ? 0.5 IU/ml at 14 days after immunization is considered a proxy for protection in vaccine efficacy studies. Abridged and dose-sparing vaccination regimens increase accessibility and reduce both direct and indirect costs, especially in resource-constrained countries where RABV prevalence is highest. Several efficacy studies evaluated safety and immunogenicity of abridged regimens in healthy adult volunteers using either four-site intradermal (ID) or…
Read more